Cannabis Therapy Provides Details on New Canna-Pet™ Lineup

Cannabis Therapy Corp. (OTC: CTCO), a development stage company that aims to become a leader in the research, development, and commercialization of safe, all-natural, ultra-low THC, cannabinoid-based medicinal therapies and supplements, recently announced additional information regarding its Canna-Pet™ product mix and upcoming marketing plans regarding its exclusive worldwide licensing agreement. “The ‘natural health’ sub-segment of the…

The post Cannabis Therapy Provides Details on New Canna-Pet™ Lineup appeared first on Marijuana Index.